Compare NOW & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NOW | BSX |
|---|---|---|
| Founded | 2004 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 162.2B | 137.8B |
| IPO Year | 2012 | 1992 |
| Metric | NOW | BSX |
|---|---|---|
| Price | $154.70 | $95.83 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 31 | 17 |
| Target Price | ★ $223.29 | $125.88 |
| AVG Volume (30 Days) | 9.0M | ★ 10.5M |
| Earning Date | 01-28-2026 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 28.67 | ★ 54.68 |
| EPS | 1.65 | ★ 1.87 |
| Revenue | $12,667,000,000.00 | ★ $19,349,000,000.00 |
| Revenue This Year | $21.62 | $21.05 |
| Revenue Next Year | $18.34 | $11.43 |
| P/E Ratio | $92.75 | ★ $51.40 |
| Revenue Growth | 21.05 | ★ 21.61 |
| 52 Week Low | $135.73 | $85.98 |
| 52 Week High | $239.62 | $109.50 |
| Indicator | NOW | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 7.98 | 46.82 |
| Support Level | $151.15 | $90.42 |
| Resistance Level | $809.66 | $93.89 |
| Average True Range (ATR) | 18.31 | 2.28 |
| MACD | -67.49 | 0.08 |
| Stochastic Oscillator | 0.41 | 45.66 |
ServiceNow Inc provides software solutions to structure and automate various business processes via a SaaS delivery model. The company primarily focuses on the IT function for enterprise customers. ServiceNow began with IT service management, expanded within the IT function, and more recently directed its workflow automation logic to functional areas beyond IT, notably customer service, HR service delivery, and security operations. ServiceNow also offers an application development platform as a service.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.